$FSLR

Should You Buy First Solar Stock For Its Cash?

First Solar (FSLR) trades 45.2% below its June 2026 high, with a 12-month free cash yield of 8.0%. The company increased cash to $1.73B, reduced debt, and reported a 33.6% operating margin. Revenue rose 23.8% to $5.38B, but 2026 sales guidance is lower. Management cites policy and cost pressures. FSLR stock is at 10.7x earnings, with next report due October 29, 2026.

Original reporting
Published Oct 21, 2026, 7:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 7:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Should You Buy First Solar Stock For Its Cash? — source image
Decision brief

The 30-second read

$FSLRNeutralLow
01

Why it matters

The analysis suggests the stock may be undervalued on cash metrics, yet operational headwinds could limit upside.

02

Market read

Provides a valuation perspective on First Solar without new material news; relevance for traders is limited.

03

What to watch

Potential impact of the pending polysilicon investigation and rising commodity costs on future cash generation.

Relevance 4/10Novelty 2/10Timing: none

Background

First Solar's free‑cash yield is unusually high after a recent cash buildup, but sales guidance has been lowered and costs are rising.

Company-level read

Ticker impact

$FSLRNeutralMedium confidence
Context

The article discusses First Solar's high free‑cash yield and recent cash balance, indicating a potential valuation consideration for the stock.

Expected impact

possible modest pressure if cash flow concerns materialize, but no clear directional catalyst.

Evidence & confidence

The piece provides analysis rather than new data; traders may watch cash flow trends but lack a concrete trigger.

Market effects

Highlights cash yield considerations for the solar equipment sector, but no sector‑wide catalyst.

U.S. solar manufacturers may see investor scrutiny on balance‑sheet strength.

Limited; primarily relevant to investors tracking First Solar.

Counterpoint

Despite a high cash yield, the declining sales guidance could signal underlying demand weakness.

Key entities

  • First Solar

    U.S. solar module manufacturer (ticker FSLR).

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$FSLRHigh

Why First Solar (FSLR) Stock Is Up Today

First Solar (FSLR) stock rose 1.8% after Truist Securities upgraded it to Buy with a $229 price target, citing improved pricing and demand forecasts. Shares later cooled to $180.10, up 1.3%. The upgrade follows a 32% YTD decline, with the analyst noting strong domestic demand and anti-stockpiling restrictions benefiting the company.

$FSLRHigh

Truist upgrades First Solar stock rating on stronger pricing outlook

Truist upgraded First Solar (FSLR) to Buy, raising its price target to $270 from $229. The upgrade is based on stronger pricing outlook and valuation reset, with a 17% increase in 2029 U.S. module ASP estimates. Truist forecasts strong U.S. solar installations and cites regulatory support. Other analysts have also upgraded FSLR, citing undervaluation and potential earnings drivers.

$FSLRHigh

Why is First Solar stock up over 2% today?

First Solar (FSLR) stock rose 2.4% in pre-market trading after Truist Securities upgraded it to 'Buy' and raised its price target to $270, citing favorable pricing and regulatory conditions. The stock is still below its 52-week high of $320.95. Analysts have largely positive ratings, with 26 Buys, 9 Holds, and 1 Sell. The broader market is mixed ahead of bank earnings season.